George Clinical Case Studies

Global and National Scientific Leadership Helps Move Potential Breakthrough CKD Anemia Treatment Forward.

Exceptional kidney and metabolic scientific leadership network provides continuity, communication and cultural expertise in long-term global trial program.   Background The National Institute of Diabetes and Digestive and Kidney Diseases (NIH) estimates that more than one in seven people with kidney disease have anemia, increasing their chance of developing heart problems and strokes. The prevalence […]

Read More

February 3rd, 2022

Insight from George Clinical Scientific Team on Leading the Global, Multi-Trial, Long-term ASCEND Program

The ASCEND program assessing the efficacy and safety of daprodustat for the treatment of anemia due to CKD across the CKD disease course is comprised of five Phase III studies. The program has enrolled over 8,000 patients who were treated for up to 4.26 years and spanned more than 35 countries. George Clinical was involved […]

Read More

January 11th, 2022

Add George Clinical to your network